ISSN: 2578-5044
Authors: Divocha VA
The work investigated changes in biochemical parameters of healthy people and patients with symptoms of acute respiratory viral infections. In practically healthy people, the content of the trypsin-like proteinase inhibitor in the oral fluid exceeded the activity of trypsin-like proteinases 1.5 thousand times. In patients with ARVI symptoms, an increase in the content of trypsin-like proteinase inhibitor was observed between the ages of 18 and 30, while in the older age group (over 50), the activity of the inhibitor decreased. There was an increase in the activity of trypsin-like proteinases in the 2nd age group (30-50 years).
Keywords: Oral Fluid; Trypsin-Like Proteinase Inhibitors; SARS